Surgical Management of Renal Cell Carcinoma

Bradley C. Leibovich, Michael L. Blute

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.

Original languageEnglish (US)
Pages (from-to)552-562
Number of pages11
JournalSeminars in Oncology
Volume33
Issue number5
DOIs
StatePublished - Oct 2006

Fingerprint

Renal Cell Carcinoma
Neoplasms
Nephrons
Drug Therapy
Incidence
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Surgical Management of Renal Cell Carcinoma. / Leibovich, Bradley C.; Blute, Michael L.

In: Seminars in Oncology, Vol. 33, No. 5, 10.2006, p. 552-562.

Research output: Contribution to journalArticle

Leibovich, Bradley C. ; Blute, Michael L. / Surgical Management of Renal Cell Carcinoma. In: Seminars in Oncology. 2006 ; Vol. 33, No. 5. pp. 552-562.
@article{e1230594379147f098b6c8157c44aa32,
title = "Surgical Management of Renal Cell Carcinoma",
abstract = "Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.",
author = "Leibovich, {Bradley C.} and Blute, {Michael L.}",
year = "2006",
month = "10",
doi = "10.1053/j.seminoncol.2006.06.007",
language = "English (US)",
volume = "33",
pages = "552--562",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Surgical Management of Renal Cell Carcinoma

AU - Leibovich, Bradley C.

AU - Blute, Michael L.

PY - 2006/10

Y1 - 2006/10

N2 - Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.

AB - Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.

UR - http://www.scopus.com/inward/record.url?scp=33749446478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749446478&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2006.06.007

DO - 10.1053/j.seminoncol.2006.06.007

M3 - Article

C2 - 17045084

AN - SCOPUS:33749446478

VL - 33

SP - 552

EP - 562

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 5

ER -